Meghan Scanlon Boston Scientific Corp (BSX) insider trading activity

Meghan Scanlon is SVP,Pres,Urology Pelvic Health of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 24,461 shares of BSX, which is worth approximately $2.24 Million. The most recent transaction as insider was on May 01, 2022, when has been sold 606 shares (Common Stock) at a price of $42.11 per share, resulting in proceeds of $25,519. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.5K

0% 3M change

0% 12M change

Total Value Held $2.24 Million

Meghan Scanlon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2022	SELL Payment of exercise price or tax liability	$25,519 $42.11 p/Share	606 Reduced 2.42%	24,461 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	2,062 Added 7.6%	25,067 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$13,251 $44.17 p/Share	300 Reduced 1.29%	23,005 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	1,019 Added 4.19%	23,305 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$9,744 $42.55 p/Share	229 Reduced 1.02%	22,286 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	779 Added 3.34%	22,515 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$13,914 $42.55 p/Share	327 Reduced 1.48%	21,736 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	1,112 Added 4.8%	22,063 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$21,158 $42.83 p/Share	494 Reduced 2.3%	20,951 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	-	1,583 Added 6.87%	21,445 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$17,076 $44.01 p/Share	388 Reduced 1.92%	19,862 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	1,108 Added 5.19%	20,250 Common Stock
Jul 27 2021	SELL Open market or private sale	$623,388 $45.01 p/Share	13,850 Reduced 41.98%	19,142 Common Stock
Jul 27 2021	BUY Exercise of conversion of derivative security	$324,228 $23.41 p/Share	13,850 Added 29.57%	32,992 Common Stock
Jul 01 2021	SELL Payment of exercise price or tax liability	$10,883 $43.36 p/Share	251 Reduced 1.34%	18,434 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	-	855 Added 4.38%	18,685 Common Stock
Jun 24 2021	SELL Open market or private sale	$724,293 $44.03 p/Share	16,450 Reduced 47.99%	17,830 Common Stock
Jun 24 2021	BUY Exercise of conversion of derivative security	$283,927 $17.26 p/Share	16,450 Added 32.43%	34,280 Common Stock
May 01 2021	SELL Payment of exercise price or tax liability	$26,378 $43.6 p/Share	605 Reduced 3.28%	17,830 Common Stock
May 01 2021	BUY Exercise of conversion of derivative security	-	2,061 Added 10.06%	18,435 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$11,595 $38.78 p/Share	299 Reduced 1.79%	16,374 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	1,018 Added 5.75%	16,673 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$13,250 $39.2 p/Share	338 Reduced 2.11%	15,655 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	1,159 Added 6.76%	15,993 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$8,481 $38.03 p/Share	223 Reduced 1.48%	14,834 Common Stock

Also insider at

FNA

Paragon 28, Inc. Healthcare

Meghan Scanlon

SVP,Pres,Urology Pelvic Health

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account